TAS 102 mechanism of action compared to 5-FU
Por um escritor misterioso
Descrição
TAS-102 monotherapy for pretreated metastatic colorectal cancer: a
Figure 6 from Crucial roles of thymidine kinase 1 and deoxyUTPase
TAS-102, a novel antitumor agent: A review of the mechanism of
TAS 102 mechanism of action compared to 5-FU
5-Fluorouracil: mechanisms of action and clinical strategies
Comparison of the mechanisms of action of TAS-102 and 5-FU. 5-FU
Frontiers A Comparison of Bevacizumab Plus TAS-102 and TAS-102
The mechanism underlying resistance to 5‑fluorouracil and its
Dihydrofluorouracil - an overview
Trifluridine/tipiracil: A practical guide to its use in the
Efficacy of Combination Chemotherapy Using a Novel Oral
TAS-102 with or without bevacizumab in patients with
Efficacy of trifluridine and tipiracil (TAS-102) versus placebo
Biology, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
